Abu-Zaid A, Alzayed M, Albahrani S, Almaqhawi A, Al Shaikh M, Baradwan S
Medicina (Kaunas). 2025; 61(2).
PMID: 40005397
PMC: 11857371.
DOI: 10.3390/medicina61020280.
Landowska M, Kaluza B, Watala C, Babula E, Zuk-Lapan A, Wozniak K
J Clin Med. 2025; 14(3).
PMID: 39941639
PMC: 11818120.
DOI: 10.3390/jcm14030969.
Khaleqsefat E, Rasul K, Kheder R, Baban S, Baban J
Sci Rep. 2025; 15(1):288.
PMID: 39747109
PMC: 11695833.
DOI: 10.1038/s41598-024-75461-7.
Tang Y, Li L, Li J
Front Endocrinol (Lausanne). 2025; 15:1499120.
PMID: 39741881
PMC: 11685072.
DOI: 10.3389/fendo.2024.1499120.
Astan R, Patoulias D, Ninic A, Dayanan R, Karakasis P, Mercantepe T
J Clin Med. 2024; 13(22).
PMID: 39598120
PMC: 11594692.
DOI: 10.3390/jcm13226976.
The Role of FTO Risk Haplotype in Overweight/Obesity and Lipid Parameters-Results From the Central China Population Study.
Ning M, Chen L, Wang Y, Xu A, Zeng R, Zhang H
Int J Endocrinol. 2024; 2024:8062791.
PMID: 39483856
PMC: 11527535.
DOI: 10.1155/2024/8062791.
Physical activity modifies the association between atherogenic index of plasma and prediabetes and diabetes: A cross-sectional analysis.
Yang S, Gou X, Dong H, Chen L, Wang Y, Wu J
J Diabetes. 2024; 16(10):e70006.
PMID: 39397263
PMC: 11471440.
DOI: 10.1111/1753-0407.70006.
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions.
Caturano A, Vetrano E, Galiero R, Sardu C, Rinaldi L, Russo V
Int J Mol Sci. 2024; 25(18).
PMID: 39337658
PMC: 11432093.
DOI: 10.3390/ijms251810173.
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk....
Kim N, Lee J, Chon S, Yu J, Jeong I, Lim S
Endocrinol Metab (Seoul). 2024; 39(5):722-731.
PMID: 39174014
PMC: 11525705.
DOI: 10.3803/EnM.2024.1995.
Changes in Haematological Parameters and Lipid Profiles in Diabetes Mellitus: A Literature Review.
Mbah J, Bwititi P, Gyawali P, Nwose E
Cureus. 2024; 16(7):e64201.
PMID: 39130996
PMC: 11310571.
DOI: 10.7759/cureus.64201.
Insulin-Heart Axis: Bridging Physiology to Insulin Resistance.
Caturano A, Galiero R, Vetrano E, Sardu C, Rinaldi L, Russo V
Int J Mol Sci. 2024; 25(15).
PMID: 39125938
PMC: 11313400.
DOI: 10.3390/ijms25158369.
Diabetic dyslipidemia and its predictors among people with diabetes in Ethiopia: systematic review and meta-analysis.
Azagew A, Abate H, Mekonnen C, Mekonnen H, Tezera Z, Jember G
Syst Rev. 2024; 13(1):190.
PMID: 39033198
PMC: 11264949.
DOI: 10.1186/s13643-024-02593-2.
Aggravating effect of abnormal low-density protein cholesterol level on coronary atherosclerotic plaque in type 2 diabetes mellitus patients assessed by coronary computed tomography angiography.
Jiang Y, Gao Y, Zhang Y, Min C, Shen L, Yan W
Cardiovasc Diabetol. 2024; 23(1):234.
PMID: 38965584
PMC: 11225366.
DOI: 10.1186/s12933-024-02304-0.
Antidiabetic Effect of Leaves in High Fat-Diet/Streptozotocin-Induced Diabetic Mice.
Rey D, Echeverry S, Valderrama I, Rodriguez I, Ospina L, Silva F
Nutrients. 2024; 16(11).
PMID: 38892601
PMC: 11174837.
DOI: 10.3390/nu16111669.
Nrf2 Signaling Pathway as a Key to Treatment for Diabetic Dyslipidemia and Atherosclerosis.
Yi M, Toribio A, Salem Y, Alexander M, Ferrey A, Swentek L
Int J Mol Sci. 2024; 25(11).
PMID: 38892018
PMC: 11172493.
DOI: 10.3390/ijms25115831.
Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis.
Kothari V, Ho T, Cabodevilla A, He Y, Kramer F, Shimizu-Albergine M
Circ Res. 2024; 135(2):335-349.
PMID: 38828596
PMC: 11223987.
DOI: 10.1161/CIRCRESAHA.123.323100.
Protective effects of swimming exercises and metformin on cardiac and aortic damage caused by a high-fat diet in obese rats with type 2 diabetes, by regulating the Bcl2/Bax signaling pathway.
Ozudogru E, Atay E, Savran M, Asci H, Ozmen O, Topsakal S
Turk J Med Sci. 2024; 53(6):1582-1592.
PMID: 38813486
PMC: 10760592.
DOI: 10.55730/1300-0144.5727.
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.
Bays H, Kirkpatrick C, Maki K, Toth P, Morgan R, Tondt J
Obes Pillars. 2024; 10:100108.
PMID: 38706496
PMC: 11066689.
DOI: 10.1016/j.obpill.2024.100108.
Associations between remnant cholesterol levels and mortality in patients with diabetes.
Pan D, Xu L, Zhang L, Shi D, Guo M
World J Diabetes. 2024; 15(4):712-723.
PMID: 38680693
PMC: 11045415.
DOI: 10.4239/wjd.v15.i4.712.
Lipid regulation of the glucagon receptor family.
Oqua A, Manchanda Y, McGlone E, Jones B, Rouse S, Tomas A
J Endocrinol. 2024; 261(3).
PMID: 38614123
PMC: 11103681.
DOI: 10.1530/JOE-23-0335.
